GC33
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for GC33, covering 2012-10-17 to 2014-10-03. Get the full timeline:
Most recent: Clinical Trial Update: Study of GC33 and Sorafenib in Combination in Advanced or Metastatic Liver Cancer (Hepatocellular Carcinoma) [Phase 1]